Valuation: LENSAR, Inc.

Market Cap 66.96M 60.05M 54.88M 50.1M 94.39M 6.29B 97.37M 662M 264M 3.36B 251M 246M 10.6B P/E 2026 *
6.41x
P/E 2027 * -24.2x
Enterprise Value 66.96M 60.05M 54.88M 50.1M 94.39M 6.29B 97.37M 662M 264M 3.36B 251M 246M 10.6B EV / Sales 2026 *
1.09x
EV / Sales 2027 * 0.92x
Free-Float
78.48%
Yield 2026 *
-
Yield 2027 * -
1 day-0.91%
1 week-6.68%
Current month-6.68%
1 month-18.66%
3 months-4.97%
6 months+1.21%
Current year-53.14%
1 week 5.34
Extreme 5.335
5.94
1 month 5.34
Extreme 5.335
6.54
Current year 4.95
Extreme 4.95
12.94
1 year 4.95
Extreme 4.95
12.94
3 years 1.8
Extreme 1.8
17.31
5 years 1.8
Extreme 1.8
17.31
10 years 1.8
Extreme 1.8
17.31
Manager TitleAgeSince
Chief Executive Officer 70 2012-01-31
Director of Finance/CFO 52 2026-05-28
Chief Operating Officer 55 2007-12-31
Director TitleAgeSince
Director/Board Member 70 2012-01-31
Chairman 80 2017-11-07
Director/Board Member 78 2018-02-01
Date Insider Type Main position Quantity % Market Cap. Importance
6/3/26 Free

Controller/Auditor

13,066 0.1079%
6/3/26
North Run Capital LP
OtherCompany 0 0% -
6/3/26 Free

Chief Executive Officer

130,662 1.0795%
Change 5-day change 1-year change 3-year change Capi.($)
-0.91%-6.68%-52.36%+148.86% 67.57M
+2.63%-0.32%+22.75%+52.69% 251B
-3.36%+4.81%-17.34%+63.31% 162B
+1.73%-0.85%+9.29%+17.76% 159B
-4.23%+1.83%-56.84%-19.05% 64.7B
+1.31%+11.01%+23.90%+52.22% 57.97B
-0.76%+4.13%+0.84%-6.12% 56.21B
-2.05%-2.95%+4.30%+54.85% 50.21B
+1.73%-0.06%+18.49%+62.52% 48.43B
+1.00%-1.11%+23.29%+81.48% 44.51B
Average -0.29%+0.63%-2.37%+50.85% 89.46B
Weighted average by Cap. +0.19%+1.29%+4.77%+41.58%

Financials

2026 *2027 *
Net sales 61.3M 54.98M 50.25M 45.87M 86.42M 5.76B 89.14M 606M 242M 3.07B 230M 225M 9.71B 72.77M 65.26M 59.65M 54.45M 103M 6.84B 106M 719M 287M 3.65B 273M 267M 11.52B
Net income 37.7M 33.81M 30.9M 28.21M 53.15M 3.54B 54.82M 372M 149M 1.89B 142M 138M 5.97B -2.83M -2.54M -2.32M -2.12M -3.99M -266M -4.12M -27.99M -11.16M -142M -10.63M -10.41M -449M
Net Debt - -
Projected Income Statement - Annual - LENSAR, Inc.
Logo LENSAR, Inc.
LENSAR, Inc. is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. The Company's product portfolio includes the LENSAR Laser System and the ALLY Robotic Cataract Laser System and their associated consumable components. It has developed its ALLY System as a compact, highly ergonomic system utilizing an extremely fast dual-modality laser and integrating artificial intelligence into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing its advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite. ALLY allows the surgeon to switch between cataract laser and the surgeon’s existing phacoemulsification device without moving patients from room-to-room. ALLY includes its proprietary Streamline software technology.
Employees
150
Date Price Change Volume
26-11-06 US$5.450 -0.91% 79,082
26-11-05 US$5.500 -5.82% 38,135
26-11-04 US$5.840 +4.85% 78,355
26-11-03 US$5.570 -1.76% 101,818
26-11-02 US$5.670 -2.91% 70,189
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - LENSAR, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.450USD
Average target price
11.33USD
Spread / Average Target
+107.95%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LENSAR, Inc.
  1. Stock Market
  2. Stocks
  3. LNSR Stock